Quantum Cyber N.V. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Quantum Cyber N.V. (QUCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 6.42 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-31
- Quantum Cyber N.V. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 6.42K shares, a 17.40% decline from fiscal 2024.
- Quantum Cyber N.V. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 7.77K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|
| 2025-12-31 | 6.42K shares 10-K · filed 2026-03-31 |
| 2024-12-31 | 7.77K shares 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |